—
C+
C+ The full Closelooknet — membership. Open the C+ overview

ResMed Inc (RMD) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for RMD, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25
How it trades on rate days beta 0.39 to TLT · on the worst bond days it moved with the market

How it trades on rate days

How RMD has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.39 — shows only a loose link to bond moves for every 1% move in TLT (20+ year Treasuries), ResMed Inc moved 0.39% on average · correlation 0.13 · higher than 39% of US names
  • Beta, last 3 months 0.68 more rate-sensitive lately than over the year
  • On the 10 worst bond days −0.78% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days −0.18% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Medical Instruments & Supplies · United States · 8 names with week and year-to-date

Peer group

Medical Instruments & Supplies · United States

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against RMD on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — ResMed Inc

RMD in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
ResMed makes cloud-connected medical devices for diagnosing and treating sleep and breathing disorders, alongside software for home and residential care providers. Its device range includes portable sleep monitors, remote-monitoring platforms such as AirView, and patient support apps such as myAir. Its software arm, built from brands including Brightree, HealthcareFirst, MatrixCare and MEDIFOX DAN, gives home health, hospice and senior-care organisations tools for records, billing and analytics. The company runs two segments, Sleep and Breathing Health, and Residential Care Software, and is based in San Diego, selling to clinics, hospitals and homes worldwide.
Where it sits in the stack
ResMed holds no seat in our AI build-out index; within our wider universe it sits in Healthcare, in the medical instruments and supplies sleeve, covering connected diagnostic devices and care-management software rather than any compute or chip layer.
Who it is priced against
Closelooknet's peer group does not name a comparison set for ResMed; the widely cited rival in sleep and respiratory devices is Koninklijke Philips.
Why Closelooknet tracks it
ResMed holds a seat in the S&P 500 but carries no seat in our AI build-out index and no Closelooknet score; the diary has not yet quoted or covered it in any edition.
What the diary watches
The diary watches whether the growing weight of software and remote-monitoring revenue changes how the business compares with its device-only history.

ResMed Inc (RMD) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

The Street on this name 1 analyst action on the wire · latest: price target by KeyBanc, 2026-08-31

The Street on this name

Analyst actions and the latest print for RMD from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Price target KeyBanc — target 267 from 255 Target raised to $267 from $255 (+11.1% to spot) 2026-08-31

1 action on the analyst wire since 2026-08-13: 1 target change. Analyst wire → · Earnings wire →

Dividends and capital return trailing yield 1.11%, quarterly · last 0.66 USD on 2026-08-20

Dividends and capital return

What RMD pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 2.46 USD per share · a 1.11% yield on the 2026-09-25 close 4 distributions, paid quarterly 2026-09-25
  • Change on the year +12.3% against the prior twelve months prior twelve months 2.19 USD per share
  • Last distribution 0.66 USD per share as the price series records it, within days of the ex-date 2026-08-20
  • By calendar year 2023: 0.48 USD (partial) · 2024: 2.02 USD · 2025: 2.26 USD · 2026: 1.86 USD to date first distribution recorded in the three-year window: 2023-11-08

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-09-26

Quick answers

What is ResMed Inc (RMD)?

ResMed Inc trades as RMD on the US exchange (United States) in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is RMD in a Closelooknet index?

Not currently — ResMed Inc is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-09-26.

Where does RMD trade against its moving averages?

Recovery attempt under the 200-day: Trades +0.6% vs the 50-day and -1.7% vs the 200-day average, 21.5% below the 52-week high and +23.1% off the 52-week low. Computed from daily closes. As of 2026-09-25 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does ResMed Inc trade when bond yields rise?

Over the past year ResMed Inc had a beta of 0.39 to TLT, the long-dated Treasury fund — it shows only a loose link to bond moves, higher than 39% of US names. On the 10 sessions in which long bonds fell most it moved −0.78% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

What does ResMed Inc do?

ResMed makes cloud-connected medical devices for diagnosing and treating sleep and breathing disorders, alongside software for home and residential care providers. Its device range includes portable sleep monitors, remote-monitoring platforms such as AirView, and patient support apps such as myAir. Its software arm, built from brands including Brightree, HealthcareFirst, MatrixCare and MEDIFOX DAN, gives home health, hospice and senior-care organisations tools for records, billing and analytics. Closelooknet's peer group does not name a comparison set for ResMed; the widely cited rival in sleep and respiratory devices is Koninklijke Philips.

Where does ResMed Inc sit in the AI build-out?

ResMed holds no seat in our AI build-out index; within our wider universe it sits in Healthcare, in the medical instruments and supplies sleeve, covering connected diagnostic devices and care-management software rather than any compute or chip layer. ResMed holds a seat in the S&P 500 but carries no seat in our AI build-out index and no Closelooknet score; the diary has not yet quoted or covered it in any edition.

Does ResMed Inc pay a dividend?

ResMed Inc has paid 2.46 USD per share over the last twelve months, paid quarterly, a trailing yield of 1.11% on the 2026-09-25 close; the last distribution recorded in the price series was 0.66 USD on 2026-08-20. The "Dividends and capital return" block on this page carries the lines.

What has Wall Street done on ResMed Inc recently?

The most recent analyst action on ResMed Inc on the Closelooknet wire is a price target by KeyBanc on 2026-08-31 (target 267 from 255). 1 action on the analyst wire since 2026-08-13: 1 target change. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for RMD, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Medical Instruments & Supplies. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.